Nautilus Biotechnology (NAUT) Income Statement: Revenue & Earnings

Nautilus Biotechnology Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Nautilus Biotechnology, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	286.77	0.00	0.00	0.00
Cost of Revenue	6.35	234.82	0.00	0.00	0.00
Gross Profit	-6.35	51.95	0.00	0.00	0.00
Operating Expenses
Research & Development	50.48	47.25	37.67	29.35	12.43
Selling, General & Administrative	31.00	28.90	25.95	21.15	3.31
Operating Expenses	75.12	76.15	63.62	50.50	15.74
Operating Income	-81.48	-76.15	-63.62	-50.50	-15.74
Other Income/Expense
Interest Income	10.78	12.55	5.82	0.33	0.00
Interest Expense	0.00	0.00	0.00	0.00	0.00
Other Income/Expense	10.70	-2.73	-1.01	0.17	0.14
Income
Income Before Tax	-70.78	-63.68	-57.92	-50.32	-15.62
Income Tax Expense	0.00	9.36	-3.13	-3.04	0.00
Net Income	-70.78	-63.68	-57.92	-50.32	-15.62
Net Income - Continuous Operations	-70.78	-63.68	-57.92	-50.32	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-64.43	-74.30	-62.40	-49.48	-15.03
EBIT	-75.60	-76.15	-63.62	-50.50	-15.74
Depreciation & Amortization	6.35	1.85	1.22	1.02	0.71
Earnings Per Share
Basic EPS	-1.00	-1.00	-	-1.00	-1.00
Diluted EPS	-1.00	-1.00	-	-1.00	-1.00
Basic Shares Outstanding	125.43	124.92	124.59	84.46	29.09
Diluted Shares Outstanding	125.43	124.92	124.59	84.46	29.09